Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
availability and optimal resource utilization. Three PhD studentships are available for work in the area of Digital Twins for optical networks, making use of intelligent AI-driven control planes. The work will
-
Framework Programme? Not funded by an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description PhD Researcher in Sustainable Aviation Fuel Deployment Four year
-
2024. The PhD will be part of the Dublin Chemistry Graduate Programme. For further information or to apply please email a PDF copy of a brief cover letter and CV, to [email protected] by Midday Tuesday
-
Post Summary To undertake a structured PhD in pharmaceutical innovation under the principal supervision of Professor John Gilmer with co-supervision from Professors Mantalaris and Long (Medicine
-
Post Summary The School of Pharmacy and Pharmaceutical Sciences at Trinity College, the University of Dublin, is seeking a candidate for a ‘PhD Studentship - Panoz Pharmaceutical Innovation in
-
genetic and immunophenotypic changes before they occur and can help drive the desired function. The aim of this PhD studentship is to characterize and direct cellular heterogeneity as a function of
-
Post Summary Background: Medicines optimisation improves medication appropriateness and reduces medication related adverse effects and harm. A medicines optimisation tool, OPTIMA-ID (Optimising Pharmaco-Therapy and Improving Medication for Ageing with Intellectual Disability) was recently...
-
Post Summary Applications are invited for a highly motivated PhD student to join an exciting new project that will use high density electromyography (EMG) and electroencephalography (EEG) to examine
-
of polymer nanocomposites, separation technologies, bio-based polymers, and conducting polymers and electrospun materials. An experienced researcher is required in separation technologies and wastewater
-
the patients suffering from multiple psychosocial morbidities in addition to physical symptoms. Treatment options are limited, and many patients do not respond to front-line therapeutics such as anti-TNF